Samuel Bates Martin - SVP and CFO, Celldex Therapeutics, Inc

As of August 12, 2021


Samuel Bates Martin Net Worth

  • Net worth is estimated to be at least $649.48K
  • Owns at least 29,378 units of Celldex Therapeutics, Inc stock
  • Sold an estimated value of $123.89K in the last 3 years at Celldex Therapeutics, Inc

Samuel Bates Martin Trading

  • Largest purchase of shares was 21,381 units , worth over $123.69K on August 12, 2021
  • Largest sale of shares was 2,738 units , worth over $123.89K on August 12, 2021
  • In total has made about 6 transactions over 3 years
  • Usually trades in June, with the busiest year in 2020 and 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Samuel Bates Martin Mailing Address

  • Mailing address is C/o Celldex Therapeutics, Inc. 53 Frontage Road, Suite 220 Hampton NJ 08827 NJ

Celldex Therapeutics, Inc Executive Compensation

Name
Year
Other Earnings Plans or Compensations
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Change in Pension Value
Other Compensation
Total
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/744218/000110465921055589/tm212386-1_def14a.htm

Celldex Therapeutics, Inc Insider Trading

  • The most recent transaction was 430 units bought on August 13, 2021 by Freddy A Jimenez worth over $19.9K
  • In the last 13 years, insiders at Celldex Therapeutics, Inc sold an estimated value of $21.91M and bought an estimated value of $4.24M
  • The most active traders are Gerald McMahon, Director,  Avery W Catlin, Sr. VP & CFO,  and Anthony S Marucci, President & CEO
  • Insider trading is most common in June, with the busiest year in 2018

Celldex Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1